Brief: Titan Pharmaceuticals Reports Q4 Loss Per Share $0.08
30/03/2020 21:35
March 30 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR
2019
FINANCIAL RESULTS
* Q4 LOSS PER SHARE $0.08
* Q4 REVENUE $1.2 MILLION
* AS AT DECEMBER 31, 2019, TITAN HAD CASH AND CASH
EQUIVALENTS OF
APPROXIMATELY $5.2 MILLION
* HAS SUFFICIENT FUNDS TO PLAN OPERATIONS INTO Q4 OF 2020
Source text for Eikon: ID:nPn9lwnzGa
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.